Valiant Organics Limited · NSE:VALIANTORG
Valiant Organics — Q3 FY26 Earnings Presentation
24 slides from Valiant Organics's earnings presentation, Feb 25, 2026
Slide 1: Cover letter to stock exchanges: Investors' Presentation
February 25, 2026 To, To, Listing / Compliance Department Listing / Compliance Department BSE LTD National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1, Dalal Street G Block Bandra-Kurla Complex, Mumbai- 400 001 Bandra (E), Mumbai- 400 051. SCRIP CODE – 5401
Slide 2: Earnings Presentation | Q3/9M-FY26
Earnings Presentation | Q3/9M-FY26
Slide 3: Snapshot
SNAPSHOT One of the largest chlorophenol One of the leading manufacturer of derivatives manufacturer globally Benzene derivatives products One of the largest domestic PNA One of the few commercial players in manufacturer Ortho Anisidine and Para Anisidine Diversified client base across Amongst 1st f
Slide 4: Company Overview
Company Overview Valiant Organics Limited was incorporated in 1984 by first generation technocrats and is headquartered out of Mumbai, India. The company is focused on the manufacturing and marketing of specialty chemicals which find usage in a variety of industries, including agrochemicals, pharmac
Slide 5: Chemistries And Product Basket
Chemistries And Product Basket 9M-FY26 Revenue Share Hydrogenation Ammonolysis 43% Key Products: Industries Served: Key Products: • Ortho Anisidine Industries Served: • Dyes • Para Nitro Aniline • Para Anisidine • Dyes • Pigments • Ortho Chloro Para Nitro Aniline • IPPCA • Pigments • Pharmaceutical
Slide 6: Manufacturing Footprint
Manufacturing Footprint CHLORINATION – SARIGAM HYDROGENATION & METHOXYLATION- • Capacity: 18,000 MTPA JHAGADIA UNIT 1 • Products: PCP, OCP, 2,4 DCP, 2,6 DCP, • Capacity: 28,800 MTPA 2,4,6 TCP • Products: ONA/OA, PNA/PA, IPPCA, CONVERSION PRODUCTS AMMONOLYSIS - VAPI HYDROGENATION – JHAGADIA UNIT 2 •
Slide 7: Key Strengths
Key Strengths Domain expertise and broad Plant locations are process understanding in a Wide supply chain strategically located near variety of chemistries. The provides the continuous ports to provide a executive team is made up of availability of adequate competitive advantage, first-generation te
Slide 8: Q3/9M-FY26 Highlights
Q3/9M-FY26 HIGHLIGHTS Valiant Organics Limited | Q3-2026 7
Slide 9: Consolidated Financial Highlights
CONSOLIDATED FINANCIAL HIGHLIGHTS Q3-FY26 CONSOLIDATED FINANCIAL HIGHLIGHTS 9M-FY26 CONSOLIDATED FINANCIAL HIGHLIGHTS INR 1,593 Mn INR 5,210 Mn Operational Revenue Operational Revenue INR 156 Mn INR 616 Mn Operating EBITDA Operating EBITDA 9.79% 11.82% Operating EBITDA Margin Operating EBITDA Margin
Slide 10: Q3/9M-FY26 Operational Highlights
Q3/9M-FY26 Operational Highlights • For the nine-month period ended FY26, revenue remained largely stable year-on-year, Q3-FY26 Revenue Break-up – Chemistries reflecting steady overall performance despite near-term pricing pressures. Others, 6% • Gross profit margin expanded by over 500 Bps year-on-
Slide 11: Revenues and Sales Volumes by Key Chemistries
Key Chemistries Chlorination (INR Mn) Hydrogenation (INR Mn) Ammonolysis (INR Mn) Others (INR Mn) 1,000 879 513 600 900 140 500 725 REVENUES 450 380 800 670 500 427 429 362 120 400 700 97 97 93 400 100 350 300 286 600 80 500 300 250 400 60 200 200 300 150 40 200 100 100 20 100 50 0 0 0 - Q3-FY25 Q2-
Slide 12: Quarterly Consolidated Financial Performance
Quarterly Consolidated Financial Performance Particulars (INR Mn) Q3-FY26 Q3-FY25 Y-o-Y Q2-FY26 Q-o-Q Revenue from Operations 1,593 1,869 (14.8)% 1,573 1.3% Total Expenses 1,437 1,715 (16.2)% 1,361 5.6% EBITDA 156 154 1.3% 212 (26.4)% EBITDA Margins (%) 9.79% 8.24% 155 Bps 13.48% (369) Bps Other Inc
Slide 13: YTD Consolidated Financial Performance
YTD Consolidated Financial Performance Particulars (INR Mn) 9M-FY26 9M-FY25 Y-o-Y Revenue from Operations 5,210 5,149 1.2% Total Expenses 4,594 4,815 (4.6)% EBITDA 616 334 84.4% EBITDA Margins (%) 11.82% 6.49% 533 Bps Other Income 29 80 (63.8)% Depreciation 293 266 10.2% Finance Cost 148 190 (22.1)%
Slide 14: Quarterly Standalone Financial Performance
Quarterly Standalone Financial Performance Particulars (INR Mn) Q3-FY26 Q3-FY25 Y-o-Y Q2-FY26 Q-o-Q Revenue from Operations 1,591 1,869 (14.9)% 1,572 1.2% Total Expenses 1,435 1,715 (16.3)% 1,360 5.5% EBITDA 156 154 1.3% 212 (26.4)% EBITDA Margins (%) 9.81% 8.24% 157 Bps 13.49% (368) Bps Other Incom
Slide 15: YTD Standalone Financial Performance
YTD Standalone Financial Performance Particulars (INR Mn) 9M-FY26 9M-FY25 Y-o-Y Revenue from Operations 5,207 5,149 1.1% Total Expenses 4,591 4,814 (4.6)% EBITDA 616 335 83.9% EBITDA Margins (%) 11.83% 6.51% 532 Bps Other Income 29 74 (60.8)% Depreciation 293 266 10.2% Finance Cost 148 190 (22.1)% P
Slide 16: Historical Financial Overview
HISTORICAL FINANCIAL OVERVIEW Valiant Organics Limited | Q3-2026 15
Slide 17: Historical Consolidated Income Statement
Historical Consolidated Income Statement Particulars (INR Mn) FY23 FY24 FY25 9M-FY26 Revenue from Operations 10,518 7,231 7,188 5,210 Total Expenses 8,875 6,849 6,651 4,594 EBITDA 1,643 382 537 616 EBITDA Margins (%) 15.62% 5.28% 7.47% 11.82% Other Income 80 93 86 29 Depreciation 292 349 358 293 Fin
Slide 18: Historical Consolidated Balance Sheet
Historical Consolidated Balance Sheet Particulars (INR Mn) FY24 FY25 H1-FY26 Particulars (INR Mn) FY24 FY25 H1-FY26 EQUITY 7,293 7,253 7,395 Non-Current Assets 8,352 8,269 8,786 a) Equity Share Capital 276 280 280 a) Property, Plant and Equipment 6,297 6,437 6,940 b) Other Equity 7,017 6,973 7,115 c
Slide 19: Historical Standalone Income Statement
Historical Standalone Income Statement Particulars (INR Mn) FY23 FY24 FY25 9M-FY26 Revenue from Operations 9,116 6,772 7,188 5,207 Total Expenses 7,817 6,376 6,651 4,591 EBITDA 1,299 396 537 616 EBITDA Margins (%) 14.25% 5.85% 7.47% 11.83% Other Income 29 29 81 29 Depreciation 276 340 358 293 Financ
Slide 20: Historical Standalone Balance Sheet
Historical Standalone Balance Sheet Particulars (INR Mn) FY24 FY25 H1-FY26 Particulars (INR Mn) FY24 FY25 H1-FY26 EQUITY 6,649 6,616 6,752 Non-Current Assets 7,818 7,750 7,775 a) Equity Share Capital 276 280 280 a) Property, Plant and Equipment 6,297 6,437 6,940 b) Other Equity 6,373 6,336 6,472 b)
Slide 21: Consolidated Financial Highlights
Consolidated Financial Highlights Operational Revenue (INR Mn) EBITDA (INR Mn) & EBITDA Margins (%) PAT (INR Mn) & PAT Margins (%) 1,400 10,518 10,000 1,643 1,100 1,026 17.00% 7,500 7,231 7,188 9.75% 800 12.00% 5,210 5,000 616 537 500 15.62% 175 382 7.00% 11.82% 2,500 5.28% 7.47% 200 3.36% - 2.00% -
Slide 22: Capital Market Information
Capital Market Information Share Price up to 31st December, 2025 70% 50% 30% 10% -10% -30% -50% -70% Jan-25 Feb-25 Mar-25 Apr-25 May-25 Jun-25 Jul-25 Aug-25 Sep-25 Oct-25 Nov-25 Dec-25 Valiant Organics Sensex Price Data (As of 31st December, 2025) INR Shareholding pattern (As of 31st December, 2025)
Slide 23: Disclaimer
Disclaimer Valiant Organics Limited No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all event
Slide 24: Thank You
THANK YOU Valiant Organics Limited | Q3-2026 23